1
|
Visible-light-promoted aerobic oxidation of sulfides and sulfoxides in ketone solvents. Tetrahedron 2022. [DOI: 10.1016/j.tet.2022.132708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
2
|
Xie L, Li R, Zheng B, Xie Z, Fang X, Wang Y, Cuny GD, Li Z, Lin B, Chen X, Hu M. Development of Rofecoxib-Based Fluorescent Probes and Investigations on Their Solvatochromism, AIE Activity, Mechanochromism, and COX-2-Targeted Bioimaging. Anal Chem 2021; 93:11991-12000. [PMID: 34424685 DOI: 10.1021/acs.analchem.1c01978] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Cyclooxygenase-2 (COX-2) fluorescent probes are promising tools for early diagnosis of cancer. Traditionally, COX-2 probes were designed by connecting two parts, a fluorophore and a COX-2 binding unit, via a flexible linker. Herein, a new class of COX-2-specific fluorescent probes have been developed via one-step modification from rofecoxib by an integrative approach to combine the binding unit and the fluorophore into one. Among them, several new rofecoxib analogues not only exhibited still potent COX-2 binding ability but also exhibited attractive fluorescence properties, such as tunable blue-red emission, solvatochromism, aggression-induced emission behavior, and mechanochromism. Notably, the emission of 2a16 can be switched between green-yellow in the crystalline state and red-orange in the amorphous state by grinding and fuming treatments. Furthermore, the highly fluorescent compound 2a16 (Φf = 0.94 in powder) displayed a much stronger fluorescence imaging of COX-2 in HeLa cancer cells overexpressing COX-2 than RAW264.7 normal cells with a minimal expression of COX-2. Most importantly, 2a16 can light up human cancer tissues from adjacent normal tissues with a much brighter fluorescence by targeting the COX-2 enzyme. These results demonstrated the potential of 2a16 as a new red fluorescent probe for human cancer imaging in clinical applications.
Collapse
Affiliation(s)
- Lijun Xie
- Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian 350007, P.R. China.,Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Renfu Li
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, P.R. China
| | - Biyun Zheng
- Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350007, P.R. China
| | - Zuoxu Xie
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Xuefen Fang
- Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350007, P.R. China
| | - Yanqi Wang
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, P.R. China
| | - Gregory D Cuny
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Zhenli Li
- Department of Medicinal Chemistry, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P.R. China
| | - Bin Lin
- Department of Medicinal Chemistry, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P.R. China
| | - Xueyuan Chen
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, P.R. China
| | - Ming Hu
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| |
Collapse
|
3
|
Mowery P, Filkorn MM, Hurysz B, Kwansare DO, Lafferty MM, McFadden MA, Neerukonda ND, Patel RR, Pierce K, Sockett KA, Truax NJ, Webster NR, Pelkey ET. Discovery of an indole-substituted furanone with tubulin polymerization inhibition activity. Bioorg Med Chem Lett 2021; 41:127991. [PMID: 33775833 DOI: 10.1016/j.bmcl.2021.127991] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2020] [Revised: 03/16/2021] [Accepted: 03/18/2021] [Indexed: 11/17/2022]
Abstract
Analogs of diarylpyrrolinone lead compound 1 were prepared and tested for anti-proliferative activity in U-937 cancer cells. Alterations of 1 focused on modifying the two nitrogen atoms: a) the pyrrolinone nitrogen atom was substituted with a propyl group or replaced with an oxygen atom (furanone), and b) the substituents on the indole nitrogen were varied. These changes led to the discovery of a furanone analog 3b with sub-micromolar anti-cancer potency and tubulin polymerization inhibition activity.
Collapse
Affiliation(s)
- Patricia Mowery
- Department of Biology, Hobart and William Smith Colleges, Geneva, NY 14456, USA.
| | - Madison M Filkorn
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Brianna Hurysz
- Department of Biology, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Deborah O Kwansare
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Megan M Lafferty
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Marissa A McFadden
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Namita D Neerukonda
- Department of Biology, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Roslyn R Patel
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Kelsey Pierce
- Department of Biology, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Kaitlynn A Sockett
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Nathanyal J Truax
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Nathan R Webster
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA
| | - Erin T Pelkey
- Department of Chemistry, Hobart and William Smith Colleges, Geneva, NY 14456, USA.
| |
Collapse
|
4
|
Xie L, Li R, Zheng B, Xie Z, Fang X, Dai T, Wang X, Li L, Wang L, Cuny GD, Eriksen J, Tu D, Chen Z, Wang X, Chen X, Hu M. One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging. ACS APPLIED BIO MATERIALS 2021; 4:2723-2731. [PMID: 35014311 DOI: 10.1021/acsabm.0c01634] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
COX-2 fluorescent probes are promising tools for cancer diagnosis. Such probes have been conventionally designed by conjugating a fluorophore to COX-2 inhibitors through lengthy synthetic processes. Herein, a type of fluorescent probe for COX-2 imaging has been developed using a single-step process from rofecoxib. In total, six rofecoxib analogues were designed using this unique strategy. Several analogues retained comparative COX-2 targeting activity of rofecoxib and also exhibited attractive fluorescent properties, which were investigated using a combination of experimental and theoretical approaches. The most potent analogue, 2a1, displayed strong fluorescent imaging of COX-2 in HeLa cells overexpressing COX-2 compared to Raw 264.7 cells and celecoxib-treated HeLa cells that expressed low levels of COX-2. Notably, our studies indicate that 2a1 can differentiate human cancer tissue from adjacent tissue with much brighter fluorescence either in histological section or cultured 3D organoids. These results illustrate the potential of 2a1 as a COX-2 near infrared fluorescent probe for human cancer imaging in clinical settings.
Collapse
Affiliation(s)
- Lijun Xie
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States.,Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian 350007, PR China
| | - Renfu Li
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, PR China
| | - Biyun Zheng
- Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, PR China
| | - Zuoxu Xie
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Xuefen Fang
- Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, PR China
| | - Tao Dai
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, PR China
| | - Xinli Wang
- Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, PR China
| | - Li Li
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Liye Wang
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Gregory D Cuny
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Jason Eriksen
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| | - Datao Tu
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, PR China
| | - Zhuo Chen
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, PR China
| | - Xiaozhong Wang
- Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, PR China
| | - Xueyuan Chen
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, PR China
| | - Ming Hu
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
| |
Collapse
|
5
|
Delcaillau T, Boehm P, Morandi B. Nickel-Catalyzed Reversible Functional Group Metathesis between Aryl Nitriles and Aryl Thioethers. J Am Chem Soc 2021; 143:3723-3728. [DOI: 10.1021/jacs.1c00529] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
| | - Philip Boehm
- ETH Zürich, Vladimir-Prelog-Weg 3, HCI, 8093 Zürich, Switzerland
| | - Bill Morandi
- ETH Zürich, Vladimir-Prelog-Weg 3, HCI, 8093 Zürich, Switzerland
| |
Collapse
|
6
|
Husain A, Bhutani M, Parveen S, Khan SA, Ahmad A, Iqbal MA. Synthesis, in vitro cytotoxicity,
ADME,
and molecular docking studies of benzimidazole‐bearing furanone derivatives. J CHIN CHEM SOC-TAIP 2020. [DOI: 10.1002/jccs.202000130] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Asif Husain
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research Jamia Hamdard New Delhi India
| | - Medha Bhutani
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research Jamia Hamdard New Delhi India
| | - Shazia Parveen
- Chemistry Department, Faculty of Science Taibah University Yanbu Saudi Arabia
- Department of Chemistry, School of Chemical and Life Sciences Jamia Hamdard New Delhi India
| | - Shah Alam Khan
- College of Pharmacy National University of Science and Technology Muscat Sultanate of Oman
| | - Aftab Ahmad
- Health Information Technology Department, Faculty of Applied Studies King Abdulaziz University Jeddah Kingdom of Saudi Arabia
| | - Md Azhar Iqbal
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research Jamia Hamdard New Delhi India
| |
Collapse
|
7
|
|
8
|
Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore. Eur J Med Chem 2019; 171:66-92. [DOI: 10.1016/j.ejmech.2019.03.021] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2018] [Revised: 02/09/2019] [Accepted: 03/07/2019] [Indexed: 02/06/2023]
|
9
|
Bao M, Wang X, Qiu L, Hu W, Hong Chan PW, Xu X. Gold-Catalyzed 1,2-Acyloxy Migration/Coupling Cascade of Propargyl Diazoacetates: Synthesis of Isomycin Derivatives. Org Lett 2019; 21:1813-1817. [DOI: 10.1021/acs.orglett.9b00392] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Ming Bao
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China
- College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China
| | - Xin Wang
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China
| | - Lihua Qiu
- College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China
| | - Wenhao Hu
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China
| | - Philip Wai Hong Chan
- School of Chemistry, Monash University, Clayton, Victoria 3800, Australia
- Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom
| | - Xinfang Xu
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China
- College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China
| |
Collapse
|
10
|
Wu YC, Cao L, Mei WJ, Wu HQ, Luo SH, Zhan HY, Wang ZY. Bis-2(5H)-furanone derivatives as new anticancer agents: Design, synthesis, biological evaluation, and mechanism studies. Chem Biol Drug Des 2018; 92:1232-1240. [DOI: 10.1111/cbdd.13183] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2017] [Revised: 02/03/2018] [Accepted: 02/10/2018] [Indexed: 12/13/2022]
Affiliation(s)
- Yan-Cheng Wu
- School of Chemistry and Environment; South China Normal University; Key Laboratory of Theoretical Chemistry of Environment; Ministry of Education; Guangzhou China
- School of Chemistry and Chemical Engineering; Guangdong Pharmaceutical University; Zhongshan China
| | - Liang Cao
- School of Chemistry and Environment; South China Normal University; Key Laboratory of Theoretical Chemistry of Environment; Ministry of Education; Guangzhou China
| | - Wen-Jie Mei
- School of Pharmacy; Guangdong Pharmaceutical University; Guangzhou China
| | - Han-Qing Wu
- School of Chemistry and Environment; South China Normal University; Key Laboratory of Theoretical Chemistry of Environment; Ministry of Education; Guangzhou China
| | - Shi-He Luo
- School of Chemistry and Environment; South China Normal University; Key Laboratory of Theoretical Chemistry of Environment; Ministry of Education; Guangzhou China
| | - Hai-Ying Zhan
- School of Chemistry and Chemical Engineering; Guangdong Pharmaceutical University; Zhongshan China
| | - Zhao-Yang Wang
- School of Chemistry and Environment; South China Normal University; Key Laboratory of Theoretical Chemistry of Environment; Ministry of Education; Guangzhou China
| |
Collapse
|
11
|
Abdelazeem AH, El-Saadi MT, Said EG, Youssif BGM, Omar HA, El-Moghazy SM. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities. Bioorg Chem 2017; 75:127-138. [PMID: 28938224 DOI: 10.1016/j.bioorg.2017.09.009] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Revised: 09/07/2017] [Accepted: 09/11/2017] [Indexed: 12/22/2022]
Abstract
Over the last few decades, a growing body of studies addressed the anticancer activity of NSAIDs, particularly selective COX-2 inhibitors. However, their exact molecular mechanism is still unclear and is not fully investigated. In this regard, a novel series of compounds bearing a COXs privilege scaffold, diphenyl thiazole, was synthesized and evaluated for their anticancer activity against a panel of cancer cell lines. The most active compounds 10b, 14a,b, 16a, 17a,b and 18b were evaluated in vitro for COX-1/COX-2 inhibitory activity. These compounds were suggested to exert their anticancer activity through a multi-target mechanism based on their structural features. Thus, compounds 10b and 17b with the least IC50 values in MTT assay were tested against three known anticancer targets; EGFR, BRAF and tubulin. Compounds 10b and 17b showed remarkable activity against EGFR with IC50 values of 0.4 and 0.2μM, respectively and good activity against BRAF with IC50 values of 1.3 and 1.7μM, respectively. In contrast, they showed weak activity in tubulin polymerization assay. The in vivo anti-inflammatory potential was assessed and interestingly, compound 17b was the most potent compound. Together, this study offers some important insights into the correlation between COXs inhibition and cancer treatment. Additionally, the results demonstrated the promising activity of these compounds with a multi-target mechanism as good candidates for further development into potential anticancer agents.
Collapse
Affiliation(s)
- Ahmed H Abdelazeem
- Department of Medicinal Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.
| | - Mohammed T El-Saadi
- Department of Medicinal Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
| | - Eman G Said
- Department of Medicinal Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
| | - Bahaa G M Youssif
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt; Department of Pharmaceutical Chemistry, College of Pharmacy, Aljouf University, Aljouf, Sakaka 2014, Saudi Arabia
| | - Hany A Omar
- Sharjah Institute for Medical Research and College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Pharmacology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
| | - Samir M El-Moghazy
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
| |
Collapse
|
12
|
Niu Y, Li S, Lin Z, Liu M, Wang D, Wang H, Chen S. Development of propidium iodide as a fluorescence probe for the on-line screening of non-specific DNA-intercalators in Fufang Banbianlian Injection. J Chromatogr A 2016; 1463:102-9. [DOI: 10.1016/j.chroma.2016.08.013] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Revised: 08/02/2016] [Accepted: 08/06/2016] [Indexed: 11/27/2022]
|
13
|
Wang Z, Wong ILK, Li FX, Yang C, Liu Z, Jiang T, Jiang TF, Chow LMC, Wan SB. Optimization of permethyl ningalin B analogs as P-glycoprotein inhibitors. Bioorg Med Chem 2015; 23:5566-73. [PMID: 26233798 DOI: 10.1016/j.bmc.2015.07.027] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2015] [Revised: 07/14/2015] [Accepted: 07/16/2015] [Indexed: 11/16/2022]
Abstract
In the present study, a total of 9 novel permethyl ningalin B analogs have been synthesized and evaluated for their P-gp modulating activity in a P-gp overexpressed breast cancer cell line LCC6MDR. Among these derivatives, compound 12 with dimethoxy groups at rings A and B and tri-substitution at ring C with ortho-methoxyethylmorpholine, meta-bromo and para-benzyloxy groups displays the most potent P-gp modulating activity with EC50 of 423 nM to reverse paclitaxel resistance. It is non-toxic towards L929 fibroblast with IC50 greater than 100 μM and with selective index greater than 236. Its mechanism to reverse P-gp mediated drug resistance is by virtue of inhibiting transport activity of P-gp, restoring intracellular drug accumulation and eventually chemosensitizing the cancer cells to anticancer drug again. Moreover, compound 12 showed better solubility (405 ng/mL) than hit compound 1 in phosphate buffer (pH 4.0). In summary, our study demonstrates that permethyl ningalin B derivative 12 is non-toxic and efficient P-gp inhibitor that is a potential candidate to be used clinically to reverse P-gp mediated cancer drug resistance.
Collapse
Affiliation(s)
- Zhen Wang
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Iris L K Wong
- Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong, China; State Key Laboratory of Chirosciences, The Hong Kong Polytechnic University, China
| | - Fu Xing Li
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Chao Yang
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Zhen Liu
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Tao Jiang
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China
| | - Ting Fu Jiang
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China
| | - Larry M C Chow
- Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong, China; State Key Laboratory of Chirosciences, The Hong Kong Polytechnic University, China.
| | - Sheng Biao Wan
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
| |
Collapse
|